The U.S. Court of Appeals for the Fifth Circuit’s recent decision in Ruffin v. BP Exploration & Production, Inc., offers important guidance on expert testimony in…
The U.S. Court of Appeals for the Fifth Circuit’s recent decision in Ruffin v. BP Exploration & Production, Inc., offers important guidance on expert testimony in toxic tort cases – particularly those arising from the Deepwater Horizon oil spill. While the court declined to impose a rigid “dosage requirement” for causation, it nonetheless affirmed the exclusion of the plaintiff’s expert for analytical gaps, reinforcing the rigor required under Daubert and Federal Rule of Evidence 702.
Background: From Oil Spill Cleanup to Cancer Diagnosis
Floyd Ruffin worked as a shoreline cleanup worker for several months following the 2010 Deepwater Horizon spill. Five years later, he was diagnosed with prostate cancer and brought a claim against BP under the settlement’s Back-End Litigation Option (BELO), alleging that exposure to oil-related chemicals caused his disease.
Central to Ruffin’s case was expert testimony from a molecular epidemiologist who opined that exposure to polycyclic aromatic hydrocarbons (PAHs) – compounds found in crude oil – contributed to the development of prostate cancer.
The Legal Framework: General vs. Specific Causation
The court reaffirmed the well-established two-step framework for causation in toxic tort cases:
•General causation: whether a substance is capable of causing the injury in the general
Content Original Link:
" target="_blank">
